Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice.

Genes and immunity - 1 Dec 2007

Jørgensen T N, Roper E, Thurman J M, Marrack P, Kotzin B L

Abstract excerpt

Several studies have described a role for type I interferons (IFNalphabeta) in the initiation and/or prolongation of autoimmune diseases. Most pronounced has been the association of disease activity with what is now known as 'the interferon signature' of gene expression in peripheral blood mononuclear cells from lupus patients. In correlation, studies have shown that inhibition of IFNalphabeta signaling abrogates...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B-Lymphocytes
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Interferon-beta

Share to Lupus Nephritis

Share to Lymphocyte Activation

Share to Mice, Congenic

Share to Receptor, Interferon alpha-beta

Share to Signal Transduction

Source

Identifiers

PMID: 17882225
DOI: 10.1038/sj.gene.6364430

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice.PMID 17882225Read ↗

Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB MiceSemantic proximity Read ↗

Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent.Semantic proximity Read ↗

Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus.Semantic proximity Read ↗

Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.Semantic proximity Read ↗

Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed mice.Semantic proximity Read ↗

Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.Semantic proximity Read ↗

Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation.Semantic proximity Read ↗

Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease.Semantic proximity Read ↗

Mediation of nonerosive arthritis in a mouse model of lupus by interferon-alpha-stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis.Semantic proximity Read ↗

CD8 T lymphocytes infiltrate the kidneys and correlate with disease progression in B6. <i>NZMSle1/Sle2/Sle3</i> lupus miceSemantic proximity Read ↗

S100a9 Protects Male Lupus-Prone NZBWF1 Mice From Disease Development.Semantic proximity Read ↗

NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.